|
|
|
| home > white papers > Changing Structural Landscape for Comparator Drug Supply - ADAllen Pharma |
|
|
 WHITE PAPERS |
|
ADAllen Pharma
|
|
Changing Structural Landscape for Comparator Drug Supply
|
|
TransCelerate BioPharma is focused on advancing innovation in R&D,
identifying and solving common R&D challenges and further improving
patient safety, with the goal of delivering more high quality medicines
to patients. In 2013, they announced its Clinical Trial Comparator
Network initiative to show a mutual commitment to offer secure and rapid
supply of comparator drug products. The aim of this article is to
unpack the section on 'Comparator Drugs' and analyse the rationale for
attempting to achieve their objectives.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management
LONDON and NEW YORK, May 25, 2022-- uMotif today announced a
new investment of $25.5m from a fund managed by Athyrium Capital
Management, LP, the New York-based investment firm. The new funding will
support continued scale up of uMotif's unique patient-first software
platform for clinical research.
More info >> |
|
 |
White Papers |
 |
|
 |
Industry Events |
 |
Connect in Pharma
14-15 September 2022, Plaexpo, Geneva, Switzerland
The new event driving innovation for pharma and biopharma businesses,
Connect in Pharma will unite key players in Pharmaceutical and
Biopharmaceutical packaging and production in Geneva on 14 – 15
September 2022.
More info >> |
|
|
|
